Immediate Impact

3 by Nobel laureates 3 from Science/Nature 73 standout
Sub-graph 1 of 24

Citing Papers

Enhancing in situ cancer vaccines using delivery technologies
2024 StandoutNobel
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
2023 Standout
3 intermediate papers

Works of P Müller being referenced

Use of A‐type CpG oligodeoxynucleotides as an adjuvant in allergen‐specific immunotherapy in humans: a phase I/IIa clinical trial
2009

Author Peers

Author Last Decade Papers Cites
P Müller 1 8 9 111 100 15 201
Katharina Gangl 28 5 150 126 17 254
David J. Amrol 2 24 10 91 99 16 221
Rana S. Bonds 1 41 10 92 97 10 271
Joshua F. E. Koenig 4 45 4 149 113 19 288
Sergio Villazala‐Merino 2 31 10 137 120 13 252
Juan-Felipe López 3 16 23 93 58 18 239
Lorena Soto‐Retes 2 45 26 173 96 19 253
JM Hopkin 1 22 4 95 150 12 291
Hanisah Sharif 2 10 4 196 173 12 289
Shumin Liao 1 29 3 58 109 17 223

All Works

Loading papers...

Rankless by CCL
2026